Insulin resistance identifies islet antibody-positive relatives who progress to type 1 diabetes

被引：0
|
作者：
Fourlanos, S
Narendran, P
Colman, P
Harrison, L
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A6 / A6
页数：1
相关论文
共 50 条
  • [1] Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes
    Krischer, JP
    Cuthbertson, DD
    Yu, LP
    Orban, T
    Maclaren, N
    Jackson, R
    Winter, WE
    Schatz, DA
    Palmer, JP
    Eisenbarth, GS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01): : 103 - 108
  • [2] Adiponectin levels do not predict clinical onset of type 1 diabetes in antibody-positive relatives
    Truyen, I.
    De Grijse, J.
    Van Schravendijk, C.
    De Smet, D.
    Decochez, K.
    Vandemeulebroucke, E.
    Giri, M.
    Keymeulen, B.
    Mathieu, C.
    Van Gaal, L.
    De Pauw, P.
    Weets, I.
    Pipeleers, D. G.
    Gorus, F. K.
    DIABETOLOGIA, 2007, 50 (10) : 2143 - 2146
  • [3] Adiponectin levels do not predict clinical onset of type 1 diabetes in antibody-positive relatives
    I. Truyen
    J. De Grijse
    C. Van Schravendijk
    D. De Smet
    K. Decochez
    E. Vandemeulebroucke
    M. Giri
    B. Keymeulen
    C. Mathieu
    L. Van Gaal
    P. De Pauw
    I. Weets
    D. G. Pipeleers
    F. K. Gorus
    Diabetologia, 2007, 50 : 2143 - 2146
  • [4] Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk
    P. J. Bingley
    E. A. M. Gale
    Diabetologia, 2006, 49
  • [5] Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk
    Bingley, PJ
    Gale, EAM
    DIABETOLOGIA, 2006, 49 (05) : 881 - 890
  • [6] Antibody-positive patients initially treated as type 2 diabetes who rapidly progress to insulin have similar type 1 and type 2 genetic risk scores and C-peptide loss as patients with type 1 diabetes
    Simpson, V. E.
    Thomas, N.
    Hill, A. V.
    Fraser, D.
    Patel, K.
    Shields, B. M.
    McDonald, T.
    Jones, A. G.
    DIABETIC MEDICINE, 2023, 40
  • [7] Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: Identification by the diabetes prevention trial-type 1
    Greenbaum, CJ
    Schatz, DK
    Cuthbertson, D
    Zeidler, A
    Eisenbarth, GS
    Krischer, JP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03): : 1255 - 1260
  • [8] Antibody positive patients with type 2 diabetes who rapidly progress to insulin have similar characteristics and type 1 genetic risk scores as patients with type 1 diabetes
    Simpson, V.
    Thomas, N.
    Hill, A. V.
    Shields, B. M.
    Deshmukh, S.
    McDonald, T. J.
    Jones, A. G.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S40 - S40
  • [9] COMBINED ANALYSIS OF AUTOANTIBODIES IMPROVES PREDICTION OF IDDM IN ISLET-CELL ANTIBODY-POSITIVE RELATIVES
    BINGLEY, PJ
    CHRISTIE, MR
    BONIFACIO, E
    BONFANTI, R
    SHATTOCK, M
    FONTE, MT
    BOTTAZZO, GF
    GALE, EAM
    DIABETES, 1994, 43 (11) : 1304 - 1310
  • [10] Adiponectin levels decrease before clinical onset of type 1 diabetes but do not improve disease prediction in antibody-positive relatives
    De Grijse, J.
    Truyen, I.
    Van Schravendijk, C.
    De Smet, D.
    Decochez, K.
    Vandemeulebroucke, E.
    Giri, M.
    Keymeulen, B.
    Mathieu, C.
    Van Gaal, L.
    De Pauw, P.
    Weets, I.
    Pipeleers, D.
    Gorus, F.
    DIABETOLOGIA, 2007, 50 : S199 - S199
12345